Intrathecal Administration of an Anti‐nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization - C. Leiguarda; A. Villarreal; C. Potilinski; T. Pelissier; M. F. Coronel; J. Bayo; A. J. Ramos; A. Montaner; M. J. Villar; L. Constandil; Pablo R. Brumovsky (Journal of Neuroimmune Pharmacology, 2021)